Caution: JavaScript execution is disabled in your browser or for this website. You may not be able to answer all questions in this survey. Please, verify your browser parameters.

Artificial intelligence in medicine - a benefit for my PKD treatment?

The aim of this survey:

Digitalization in medicine and the use of AI (artificial intelligence) offer great potential for advancing medical research and improving patient treatment. However, the transfer of these new technologies into medical practice require the establishment of trust and acceptance among medical staff and patients.

Especially in chronic diseases, such as Autosomal Dominant Polycystic Kidney Disease (ADPKD), the use of AI promises great potential in many areas of application, such as improved prediction of disease progression, personalized treatment decisions and improved education and counseling of ADPKD patients

With this survey, we would like to gain insight into the current opinion of patients towards digitalization in medicine and the use of AI and identify new use cases for ADPKD patients.

There are 18 questions in this survey.

This survey is anonymous.

The record of your survey responses does not contain any identifying information about you, unless a specific survey question explicitly asked for it.

If you used an identifying access code to access this survey, please rest assured that this code will not be stored together with your responses. It is managed in a separate database and will only be updated to indicate whether you did (or did not) complete this survey. There is no way of matching identification access codes with survey responses.